![Anthony DiGiandomenico](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Anthony DiGiandomenico
Grundare på
MDB CAPITAL HOLDINGS, LLC
Förmögenhet: 5 M $ per 2026-06-30
Profil
Anthony DiGiandomenico is the founder of Public Ventures LLC, founded in 1997, and MDB Capital Holdings LLC, founded in 1997, where the title held is Director & Chief Transactions.
Current jobs include Independent Director at ClearSign Technologies Corp.
starting in 2025; Director at Pier Acquisition I, Inc.; Director at Pier Acquisition II, Inc.; Independent Director at ENDRA Life Sciences, Inc. since 2013; Managing Director at National Association of Securities Dealers, Inc. since 1997; Independent Director at Illumination Acquisition Corp.
I starting in 2026; and Director at eXoZymes, Inc. since 2019.
Former jobs include President & Chief Executive Officer at Digian Co.; Director at Orion Acquisition Corp.
II; Director at Charlie's Holdings, Inc. from 2004 to 2012; Director at Cue Biopharma, Inc. from 2016 to 2019; and Independent Director at Provention Bio, Inc. from 2017 to 2020.
Education includes undergraduate studies at The University of Colorado and an MBA from Haas School of Business.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2025-09-30 | 1 245 000 ( 24,9 % ) | 4 M $ | 2026-06-30 | |
| 2026-06-25 | 76 267 ( 6 % ) | 406 503 $ | 2026-06-30 | |
| 2025-09-30 | 80 693 ( 1,48 % ) | 282 426 $ | 2026-06-30 | |
| 2026-06-30 | 54 447 ( 0,88 % ) | 199 820 $ | 2026-06-30 | |
EXOZYMES INC. -.--% | 2025-06-09 | 0 ( -.--% ) | - $ | 2026-06-30 |
Aktiva positioner av Anthony DiGiandomenico
| Företag | Position | Start |
|---|---|---|
| ENDRA LIFE SCIENCES INC. | Direktör/Styrelseledamot | 2013-07-01 |
| MDB CAPITAL HOLDINGS, LLC | Grundare | 1997-01-01 |
| EXOZYMES, INC. | Direktör/Styrelseledamot | 2019-04-01 |
| CLEARSIGN TECHNOLOGIES CORPORATION | Direktör/Styrelseledamot | 2025-05-22 |
Pier Acquisition I, Inc.
 Pier Acquisition I, Inc. Financial ConglomeratesFinance Operates as a blank check company | Direktör/Styrelseledamot | 2009-11-16 |
Pier Acquisition II, Inc.
 Pier Acquisition II, Inc. Financial ConglomeratesFinance Operates as a blank check company | Direktör/Styrelseledamot | 2009-11-16 |
National Association of Securities Dealers, Inc.
 National Association of Securities Dealers, Inc. Investment Banks/BrokersFinance Provides financial regulatory services | Företagsledare/Principal | 2011-07-25 |
Tidigare kända positioner av Anthony DiGiandomenico
| Företag | Position | Slut |
|---|---|---|
| PROVENTION BIO, INC. | Direktör/Styrelseledamot | 2020-05-19 |
| CUE BIOPHARMA, INC. | Direktör/Styrelseledamot | 2019-10-03 |
| ░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░ ░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░ | - |
Anthony DiGiandomenicos utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
53
Första gradens relationer
15
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 15 |
|---|---|
Orion Acquisition Corp. II
 Orion Acquisition Corp. II Financial ConglomeratesFinance Development stage company | Finance |
Public Ventures LLC
 Public Ventures LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Charlies Holdings, Inc.
 Charlies Holdings, Inc. Industrial ConglomeratesProducer Manufacturing Manufactures and sells nicotine-based vapor products | Producer Manufacturing |
ClearSign Technologies Corp.
 ClearSign Technologies Corp. Industrial MachineryProducer Manufacturing Operates as a development stage company that designs and develops technologies for combustion systems | Producer Manufacturing |
Pier Acquisition I, Inc.
Pier Acquisition I, Inc. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Pier Acquisition II, Inc.
Pier Acquisition II, Inc. Financial ConglomeratesFinance Operates as a blank check company | Finance |
The University of Colorado
 The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ENDRA Life Sciences, Inc.
 ENDRA Life Sciences, Inc. Medical SpecialtiesHealth Technology Develops medical imaging technology solutions | Health Technology |
National Association of Securities Dealers, Inc.
National Association of Securities Dealers, Inc. Investment Banks/BrokersFinance Provides financial regulatory services | Finance |
Digian Co. | |
Haas School of Business
 Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cue Biopharma, Inc.
 Cue Biopharma, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Provention Bio, Inc.
 Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company that engages in intercepting and preventing immune-mediated diseases including type 1 diabetic activities | Health Technology |
MDB Capital Holdings LLC
 MDB Capital Holdings LLC Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Invizyne Technologies, Inc.
 Invizyne Technologies, Inc. Chemicals: SpecialtyProcess Industries Manufactures and sells chemicals for pharmaceuticals, fuels, materials, food additives & novel compounds | Process Industries |
